Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 108

1.

Monitoring health outcomes following cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis.

McQuellon RP, Danhauer SC, Russell GB, Shen P, Fenstermaker J, Stewart JH, Levine EA.

Ann Surg Oncol. 2007 Mar;14(3):1105-13. Epub 2007 Jan 6.

PMID:
17206478
[PubMed - indexed for MEDLINE]
2.

Survival and health outcomes after cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of appendiceal origin.

McQuellon RP, Russell GB, Shen P, Stewart JH 4th, Saunders W, Levine EA.

Ann Surg Oncol. 2008 Jan;15(1):125-33. Epub 2007 Nov 20.

PMID:
18030535
[PubMed - indexed for MEDLINE]
3.

Long-term survivorship and quality of life after cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis.

McQuellon RP, Loggie BW, Lehman AB, Russell GB, Fleming RA, Shen P, Levine EA.

Ann Surg Oncol. 2003 Mar;10(2):155-62.

PMID:
12620911
[PubMed - indexed for MEDLINE]
4.

Quality of life after intraperitoneal hyperthermic chemotherapy (IPHC) for peritoneal carcinomatosis.

McQuellon RP, Loggie BW, Fleming RA, Russell GB, Lehman AB, Rambo TD.

Eur J Surg Oncol. 2001 Feb;27(1):65-73.

PMID:
11237495
[PubMed - indexed for MEDLINE]
5.

Survival and quality of life following cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis of colonic origin.

Hill AR, McQuellon RP, Russell GB, Shen P, Stewart JH 4th, Levine EA.

Ann Surg Oncol. 2011 Dec;18(13):3673-9. doi: 10.1245/s10434-011-1793-1. Epub 2011 Jun 15.

PMID:
21674272
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of gastrointestinal origin.

Loggie BW, Fleming RA, McQuellon RP, Russell GB, Geisinger KR.

Am Surg. 2000 Jun;66(6):561-8.

PMID:
10888132
[PubMed - indexed for MEDLINE]
7.

Toxicity and quality of life after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy.

Tuttle TM, Zhang Y, Greeno E, Knutsen A.

Ann Surg Oncol. 2006 Dec;13(12):1627-32. Epub 2006 Oct 1.

PMID:
17013686
[PubMed - indexed for MEDLINE]
8.

[Treatment of the peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy (IHPC): postoperative morbidity and mortality and short-term follow-up].

Minicozzi A, Borzellino G, Momo EN, Segattini C, Pitoni F, Steccanella F, De Manzoni G.

Ann Ital Chir. 2008 Jul-Aug;79(4):231-9. Italian.

PMID:
19093624
[PubMed - indexed for MEDLINE]
9.

Staged laparoscopic infusion of hyperthermic intraperitoneal chemotherapy after cytoreductive surgery.

Knutsen A, Sielaff TD, Greeno E, Tuttle TM.

J Gastrointest Surg. 2006 Jul-Aug;10(7):1038-43.

PMID:
16843875
[PubMed - indexed for MEDLINE]
10.
11.

Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival in selected patients with peritoneal carcinomatosis from abdominal and pelvic malignancies: results of 21 cases.

Yang XJ, Li Y, al-shammaa Hassan AH, Yang GL, Liu SY, Lu YL, Zhang JW, Yonemura Y.

Ann Surg Oncol. 2009 Feb;16(2):345-51. doi: 10.1245/s10434-008-0226-2. Epub 2008 Nov 19.

PMID:
19018599
[PubMed - indexed for MEDLINE]
12.

[New treatment of peritoneal carcinomatosis from colorectal cancer. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy].

Iversen LH, Rasmussen PC, Laurberg S.

Ugeskr Laeger. 2007 Sep 17;169(38):3179-81. Danish.

PMID:
17910824
[PubMed - indexed for MEDLINE]
13.

Predicting postoperative morbidity following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CS+HIPEC) with preoperative FACT-C (Functional Assessment of Cancer Therapy) and patient-rated performance status.

Ihemelandu CU, McQuellon R, Shen P, Stewart JH, Votanopoulos K, Levine EA.

Ann Surg Oncol. 2013 Oct;20(11):3519-26. doi: 10.1245/s10434-013-3049-8. Epub 2013 Jun 8.

PMID:
23748607
[PubMed - indexed for MEDLINE]
14.

Factors predicting survival after intraperitoneal hyperthermic chemotherapy with mitomycin C after cytoreductive surgery for patients with peritoneal carcinomatosis.

Shen P, Levine EA, Hall J, Case D, Russell G, Fleming R, McQuellon R, Geisinger KR, Loggie BW.

Arch Surg. 2003 Jan;138(1):26-33.

PMID:
12511145
[PubMed - indexed for MEDLINE]
15.

Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy with mitomycin C for peritoneal carcinomatosis from nonappendiceal colorectal carcinoma.

Shen P, Hawksworth J, Lovato J, Loggie BW, Geisinger KR, Fleming RA, Levine EA.

Ann Surg Oncol. 2004 Feb;11(2):178-86.

PMID:
14761921
[PubMed - indexed for MEDLINE]
16.

Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy in peritoneal carcinomatosis.

Nesher E, Greenberg R, Avital S, Skornick Y, Schneebaum S.

Isr Med Assoc J. 2007 Nov;9(11):787-90.

PMID:
18085034
[PubMed - indexed for MEDLINE]
Free Article
17.

Cytoreductive surgery combined with hyperthermic intraperitoneal intraoperative chemotherapy for peritoneal carcinomatosis arising from colon adenocarcinoma.

Pilati P, Mocellin S, Rossi CR, Foletto M, Campana L, Nitti D, Lise M.

Ann Surg Oncol. 2003 Jun;10(5):508-13.

PMID:
12794016
[PubMed - indexed for MEDLINE]
18.

Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: experience with 501 procedures.

Levine EA, Stewart JH 4th, Russell GB, Geisinger KR, Loggie BL, Shen P.

J Am Coll Surg. 2007 May;204(5):943-53; discussion 953-5. Erratum in: J Am Coll Surg. 2007 Oct;205(4):630.

PMID:
17481516
[PubMed - indexed for MEDLINE]
19.

Extensive cytoreductive surgery followed by intra-operative hyperthermic intraperitoneal chemotherapy with mitomycin-C in patients with peritoneal carcinomatosis of colorectal origin.

Witkamp AJ, de Bree E, Kaag MM, Boot H, Beijnen JH, van Slooten GW, van Coevorden F, Zoetmulder FA.

Eur J Cancer. 2001 May;37(8):979-84.

PMID:
11334722
[PubMed - indexed for MEDLINE]
20.

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal carcinomatosis. Preliminary results and cost from two centers in Greece.

Spiliotis J, Tentes AA, Vaxevanidou A, Korakianitis OS, Rogdakis A, Mirelis CG, Datsis AC, Kekelos S.

J BUON. 2008 Apr-Jun;13(2):205-10.

PMID:
18555466
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk